Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.

  • Hagit Baris Feldman
  • , Chofit Chai Gadot
  • , David Zahler
  • , Adi Mory
  • , Galit Aviram
  • , Emil Elhanan
  • , Gabi Shefer
  • , Ilana Goldiner
  • , Yam Amir
  • , Alina Kurolap
  • , Jacob N. Ablin

Research output: Contribution to journalArticlepeer-review

Abstract

Summary Two siblings presented with cardiomyopathy, hypertension, arrhythmia, and fibrosis of the left atrium. Each had a homozygous null variant in CORIN, the gene encoding atrial natriuretic peptide (ANP)-converting enzyme. A plasma sample obtained from one of the siblings had no detectable levels of corin or N-terminal pro-ANP but had elevated levels of B-type natriuretic peptide (BNP) and one of the two protein markers of fibrosis that we tested. These and other findings support the hypothesis that BNP cannot fully compensate for a lack of activation of the ANP pathway and that corin is critical to normal ANP activity, left atrial function, and cardiovascular homeostasis.

Original languageEnglish
Pages (from-to)1685-1692
Number of pages8
JournalNew England Journal of Medicine
Volume389
Issue number18
DOIs
StatePublished - 2 Nov 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 Massachusetts Medical Society.

Keywords

  • Arrhythmias/Pacemakers/Defibrillators
  • Cardiology
  • Cardiology General
  • Cardiomyopathy/Myocarditis/Pericarditis
  • Genetics
  • Genetics General
  • Hypertension
  • Nephrology
  • Nephrology General

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.'. Together they form a unique fingerprint.

Cite this